NeuroPace (NPCE) Change in Accured Expenses (2020 - 2026)

NeuroPace's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$4.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 71.24% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at $1.9 million (up 1045.45% YoY), while the FY2025 annual figure was $3.6 million, up 355.17% from the prior year.
• Change in Accured Expenses was -$4.0 million for Q1 2026 at NeuroPace, down from $1.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.6 million in Q3 2025 to a low of -$4.0 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged $112823.5 across 5 years, with a median of $454000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses jumped 39975.0% in 2023, then plunged 366.43% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$136000.0 in 2022, then soared by 941.91% to $1.1 million in 2023, then sank by 124.8% to -$284000.0 in 2024, then surged by 459.86% to $1.0 million in 2025, then plunged by 490.9% to -$4.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$4.0 million (Q1 2026), $1.0 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.